Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xalacom vs Xalatan and Timolol in Glaucoma and Ocular Hypertension
NCT00277498Phase 3Completed
- Sponsor
- Viatris
- Start
- Dec 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of latanoprost, timolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by Viatris. Started Dec 2005; status: completed.
02
Drugs
latanoprosttimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00277498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277498.